Blog
RSS FeedPosted by Michael Wonder on 16 Jun 2021
German law makers seek to ease reimbursement for advanced therapies
15 June 2021 - Advanced therapy trade group The Alliance for Regenerative Medicine has highlighted the passage of a new ...
Posted by Michael Wonder on 16 Jun 2021
HHS proposes rescinding Trump era insulin, epinephrine rule
15 June 2021 - The HHS is proposing to rescind a Trump administration drug rule requiring community health centers to ...
Posted by Michael Wonder on 13 Jun 2021
Unaffordable treatment for severe malaria highlights U.S. drug market pitfalls
11 June 2021 - When Eli Lilly announced in 2017 that it would stop producing quinidine, it was the only ...
Posted by Michael Wonder on 10 Jun 2021
Yuhan's Leclaza to be cheaper than AstraZeneca's Tagrisso
10 June 2021 - The price of Yuhan's third generation epidermal growth factor receptor tyrosine kinase inhibitor for treating patients ...
Posted by Michael Wonder on 09 Jun 2021
Pharma funded more than 2,400 state law maker campaigns in 2020, new STAT analysis finds
9 June 2021 - State lawmakers in Oregon have tried to lower high drug prices from nearly every angle: they’ve sought ...
Posted by Michael Wonder on 09 Jun 2021
Prescription drug price increases continue to outpace inflation
7 June 2021 - New AARP report shows even during pandemic consumers have had to pay more for medicines. ...
Posted by Michael Wonder on 08 Jun 2021
Biogen faces tough questions over $56,000 a year price of newly approved Alzheimer’s drug
8 June 2021 - The biotech company’s price for the drug is higher than the $10,000 to $25,000 some Wall Street ...
Posted by Michael Wonder on 08 Jun 2021
Biogen CEO says $56,000 annually for Alzheimer’s drug is ‘fair,’ promises not to hike price for at least 4 years
7 June 2021 - Biogen CEO Michel Vounatsos told CNBC on Monday that the list price of $56,000 per year ...
Posted by Michael Wonder on 08 Jun 2021
Despite its high price tag, the new Alzheimer’s drug isn’t reigniting the drug pricing debate
8 June 2021 - It has all the makings of a bombastic drug pricing debate: a highly anticipated drug, widespread ...
Posted by Michael Wonder on 06 Jun 2021
The parents hoped an existing drug might keep their kids from having seizures. Then they saw the price.
3 June 2021 - When Amber Freed heard in 2020 that a drug might help save her young child from ...
Posted by Michael Wonder on 05 Jun 2021
Put Canadians first by suspending the implementation of harmful drug pricing regulations
4 June 2021 - Innovative Medicines Canada calls on the federal government to suspend the implementation of the Patented Medicines ...
Posted by Michael Wonder on 05 Jun 2021
Could big pharma actually lose this fight over drug prices? It's Biden's call.
3 June 2021 - More than 20 years ago, when I was the press secretary for then-Congressman Bernie Sanders, I rode ...
Posted by Michael Wonder on 03 Jun 2021
Biden health official 'taking a look' at Trump drug pricing proposal
3 June 2021 - A key Biden administration health official said Thursday that she is "taking a look" at one ...
Posted by Michael Wonder on 31 May 2021
External reference pricing: the drug pricing reform America needs?
27 May 2021 - External reference pricing, sometimes known as international reference pricing, refers to the practice of informing price negotiations ...
Posted by Michael Wonder on 31 May 2021
White House asks court to dismiss lawsuit over drug imports
31 May 2021 - The Biden administration is urging a federal court to dismiss a lawsuit that could stand in the ...